These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine. Nakamura M; Weil WB; Kaufman DB Pediatr Nephrol; 1989 Jan; 3(1):80-2. PubMed ID: 2702092 [TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis. Andreoli SP; Dunn D; DeMyer W; Sherrard DJ; Bergstein JM J Pediatr; 1985 Nov; 107(5):760-3. PubMed ID: 3932629 [No Abstract] [Full Text] [Related]
12. Aluminum and deferoxamine kinetics in CAPD. Mactier RA Adv Perit Dial; 1991; 7():26-9. PubMed ID: 1680440 [TBL] [Abstract][Full Text] [Related]
13. Iron removal during continuous ambulatory peritoneal dialysis using deferoxamine. Falk RJ; Mattern WD; Lamanna RW; Gitelman HJ; Parker NC; Cross RE; Rastall JR Kidney Int; 1983 Jul; 24(1):110-2. PubMed ID: 6620847 [No Abstract] [Full Text] [Related]
14. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia. O'Brien AA; McParland C; Keogh JA Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649 [TBL] [Abstract][Full Text] [Related]
15. Aluminum-related osteomalacia in renal-failure patients. Vick KE; Johnson CA Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471 [TBL] [Abstract][Full Text] [Related]
16. [A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient]. Yamagata K; Kobayashi M; Koyama A; Narita M; Amagai H; Ohno A; Yoshikawa S Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):437-42. PubMed ID: 1875564 [TBL] [Abstract][Full Text] [Related]
17. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Kopple JD; Blumenkrantz MJ; Jones MR; Moran JK; Coburn JW Am J Clin Nutr; 1982 Sep; 36(3):395-402. PubMed ID: 7113946 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of intramuscular and intraperitoneal deferoxamine for aluminum chelation. Molitoris BA; Alfrey PS; Miller NL; Hasbargen JA; Kaehney WD; Alfrey AC; Smith BJ Kidney Int; 1987 Apr; 31(4):986-91. PubMed ID: 3586503 [TBL] [Abstract][Full Text] [Related]
19. Histochemical demonstration of iron but not aluminum in a case of dialysis-associated osteomalacia. Phelps KR; Vigorita VJ; Bansal M; Einhorn TA Am J Med; 1988 Apr; 84(4):775-80. PubMed ID: 3041812 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on peritoneal dialysis. Allain P; Chaleil D; Mauras Y; Varin MC; Ang KS; Cam G; Simon P Clin Chim Acta; 1988 Apr; 173(3):313-6. PubMed ID: 3383431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]